253 related articles for article (PubMed ID: 28848438)
1. Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.
Lampe JN
Front Pharmacol; 2017; 8():521. PubMed ID: 28848438
[TBL] [Abstract][Full Text] [Related]
2. Gene-environment interactions in esophageal cancer.
Matejcic M; Iqbal Parker M
Crit Rev Clin Lab Sci; 2015; 52(5):211-31. PubMed ID: 26220475
[TBL] [Abstract][Full Text] [Related]
3. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
[TBL] [Abstract][Full Text] [Related]
4. Membrane environment drives cytochrome P450's spin transition and its interaction with cytochrome b
Ravula T; Barnaba C; Mahajan M; Anantharamaiah GM; Im SC; Waskell L; Ramamoorthy A
Chem Commun (Camb); 2017 Nov; 53(95):12798-12801. PubMed ID: 29143058
[TBL] [Abstract][Full Text] [Related]
5. Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances.
Sheng Y; Yang H; Wu T; Zhu L; Liu L; Liu X
Front Pharmacol; 2021; 12():650027. PubMed ID: 33967789
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
7. Functional protein-protein interaction of drug metabolizing enzymes.
Ishii Y; Takeda S; Yamada H; Oguri K
Front Biosci; 2005 Jan; 10():887-95. PubMed ID: 15569627
[TBL] [Abstract][Full Text] [Related]
8. Interaction between cytochrome P450 and other drug-metabolizing enzymes: evidence for an association of CYP1A1 with microsomal epoxide hydrolase and UDP-glucuronosyltransferase.
Taura KI; Yamada H; Hagino Y; Ishii Y; Mori MA; Oguri K
Biochem Biophys Res Commun; 2000 Jul; 273(3):1048-52. PubMed ID: 10891369
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of polymorphic drug metabolism.
Daly AK
J Mol Med (Berl); 1995 Nov; 73(11):539-53. PubMed ID: 8751138
[TBL] [Abstract][Full Text] [Related]
10. Age, gender and region-specific differences in drug metabolising enzymes in rat ocular tissues.
Nakamura K; Fujiki T; Tamura HO
Exp Eye Res; 2005 Dec; 81(6):710-5. PubMed ID: 15967433
[TBL] [Abstract][Full Text] [Related]
11. The impact of genetic factors on response to anaesthetics.
Mikstacki A; Skrzypczak-Zielinska M; Tamowicz B; Zakerska-Banaszak O; Szalata M; Slomski R
Adv Med Sci; 2013; 58(1):9-14. PubMed ID: 23640947
[TBL] [Abstract][Full Text] [Related]
12. In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism.
Siller M; Anzenbacher P; Anzenbacherová E; Doležal K; Strnad M
Xenobiotica; 2011 Nov; 41(11):934-44. PubMed ID: 21745145
[TBL] [Abstract][Full Text] [Related]
13. Expression of drug metabolizing enzymes and transporters in the cochlea: Implications for drug delivery and ototoxicity.
Kennon-McGill S; Clemens MM; McGill MR
Hear Res; 2019 Aug; 379():98-102. PubMed ID: 31121337
[TBL] [Abstract][Full Text] [Related]
14. Drug-metabolizing enzymes: mechanisms and functions.
Sheweita SA
Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
[TBL] [Abstract][Full Text] [Related]
15. Regulation of drug-metabolizing enzymes and transporters in inflammation.
Aitken AE; Richardson TA; Morgan ET
Annu Rev Pharmacol Toxicol; 2006; 46():123-49. PubMed ID: 16402901
[TBL] [Abstract][Full Text] [Related]
16. Metabolic enzyme considerations in cancer therapy.
Jain AK; Jain S; Rana AC
Malays J Med Sci; 2007 Jan; 14(1):10-7. PubMed ID: 22593646
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.
Kim S; Choi WG; Kwon M; Lee S; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
Molecules; 2019 Aug; 24(16):. PubMed ID: 31430908
[TBL] [Abstract][Full Text] [Related]
18. Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer's disease.
Xing Y; Jia JP; Ji XJ; Tian T
Prog Neurobiol; 2013 Dec; 111():53-74. PubMed ID: 24096044
[TBL] [Abstract][Full Text] [Related]
19. Postmortem changes in drug-metabolizing enzymes of rat liver microsome.
Yamazaki M; Wakasugi C
Forensic Sci Int; 1994 Aug; 67(3):155-68. PubMed ID: 7959472
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
Iyanagi T
Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
